Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

VITILIGO: SYMPTOMS, PATHOGENESIS AND TREATMENTS BY USING DIFFERENT THERAPIES

  Authors

  Bhakti Wali,  Sardar Shelake,  Nilesh Chougule,  Siddharth Kamble,  Pranav Jadhav

  Keywords

Vitiligo, melanin, repigmentation, treatment, dermatology.

  Abstract


Vitiligo is an acquired disorder of pigmentation, caused by decreased production of melanin as a result of dysfunction of melanocytes. Hair and, in rare cases, eyes may also lose their colour. Vitiligo is a fairly frequent dermatological condition that has been documented since antiquity. The cause of vitiligo is uncertain however an autoimmune pathophysiology appears to be the most likely explanation. Because vitiligo can have a significant impact, Treatment can be considered and should preferably begin early when the disease is diagnosed because it has an impact on quality of life. The current therapy approaches are aimed at slowing the disease's course and achieving a cure repigmentation. Treatment is similarly problematic; allopathic medications are just suppressive, not therapeutic. A number of novel therapies have shown to have a lot of promise. Therapies include corticosteroids, topical immune modulators, photo (chemo) therapy, surgery, combination therapies and repigmentation of normally pigmented skin. Traditional Chinese medicine appears to be more successful than the modern vitligo treatment. Vitiligo, melanin, repigmentation, treatment, dermatology are some of the terms used to describe the condition.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2205952

  Paper ID - 220891

  Page Number(s) - i101-i109

  Pubished in - Volume 10 | Issue 5 | May 2022

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Bhakti Wali,  Sardar Shelake,  Nilesh Chougule,  Siddharth Kamble,  Pranav Jadhav,   "VITILIGO: SYMPTOMS, PATHOGENESIS AND TREATMENTS BY USING DIFFERENT THERAPIES", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.10, Issue 5, pp.i101-i109, May 2022, Available at :http://www.ijcrt.org/papers/IJCRT2205952.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper July 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer